Table 2 Baseline characteristics

Age, median (range)

59 year-old (44–73)

BRCA mutation status (germline mutation/wild type/unknown)

1/7/1

 OvCa (HGSOC/Clear cell/Mixed Mullerian/ Mixed Serous and Endometrioid)

6 (2/2/1/1)

 Platinum sensitivity in OvCa (sensitive/resistant)

2/5

 Primary Peritoneal cancer (platinum-resistant)

1

 Endometrial carcinoma (MSI low)

1

 Triple Negative Breast Cancer

1

ECOG Performance Status (0/1/2)

3/6/0

Number of previous treatments, median (range)

2 (2–6)

 Prior PARPi (n)

0

 Prior bevacizumab (n)

2